Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jenner, E., 1801. An inquiry into the causes and effects of the Variolae Vacciniae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow-pox, Third edition, D.N. Shury, London.
Coley, W. B., 1893, The treatment of malignant tumors by repeated inoculations of erysipelas with a report of ten original cases, Am. J. Med. Sci. 105:487–511.
Hall, S. S., 1997. A Commotion in the Blood. Life, Death and the Immune System, Henry Holt & Co., New York.
Gratia, A. and Linz, R., 1931, Le phénoméne de Schwartzman dans le sarcome du Cobaye, CR Séances Soc. Biol. Ses. Fil. 108:427–428.
Shear, M. J., Turner, F. C., Perrault, A. and Shovelton, T., 1943, Chemical treatment of tumors. V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate, J. Natl. Cancer Inst. 4:81–97.
Shear, M. J., 1944, Chemical treatment of tumors. IX. Reactions of mice with primary subcutaneous tumors to injection of a hemorrhage-producing bacterial polysaccharide, J. Natl. Cancer Inst. 4:461–476.
Algire, G. H., Legallais, F. Y. and Anderson, B. F., 1952, Vascular reactions of normal and malignant tissues in vivo. V. Role of hypertension in action of bacterial polysaccharide on tumors, J. Nat. Cancer Inst. 12:1279–1295.
Nowotny, A., 1969, Molecular aspects of endotoxic reactions, Bacteriol. Rev. 33:72–98.
Parr, I., Wheeler, E. and Alexander, P., 1973, Similarities of the antitumor actions of endotoxin, lipid A and double-stranded RNA, Br. J. Cancer. 27:370–389.
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B., 1975, An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci. U. S. A. 72:3666–3670.
Janeway, C. A., Jr., 1989, Approaching the asymptote? Evolution and revolution in immunology, Cold Spring Harb. Symp. Quant. Biol. 54 Pt 1:1–13.
Amos, D. B., 1986, Recollections of Dr. Peter Gorer, Immunogenetics. 24:341–344.
Ehrlich, P., 1897, Die Wertbestimmung des Diphterieheilserums und deren theoretische Grundlagen, Klinische Jahrbucher. 6:299–326.
Ehrlich, P., 1906. Collected Studies on Immunity, John Wiley & Sons, New York.
Landsteiner, K., 1901, Ueber Agglutinationserscheinungen normalen menschlichen Blutes, Wein Klin. Wochenschr. 14:1132–1134.
von Dungern, E. and Hirszfeld, L., 1911, Ueber gruppenspezifische Strukturen des Blutes III., Zeitschrift für Immunologische Forschung. 8:526–562.
Ehrlich, P. and Morgenroth, J., 1901, Ueber haemolysin, Berliner Klin. Wochenschr. 38:569.
Ehrlich, P. and Morgenroth, J., 1957. On haemolysins: Third and fifth communications, Pergamon Press, London.
Little, C. C., 1914, A possible Mendelian explanation for a type of an inheritance apparently non-Mendelian in nature, Science. 40:904–906.
Little, C. C., 1941. The genetics of tumor transplantation, Dover, New York.
Gorer, P. A., 1937a, Further studies on antigenetic differences in mouse erythrocytes, J. Pathol. Bacteriol. 44:31–36.
Gorer, P. A., 1937b, The genetic and antigenetic basis of tumour transplantation, J. Pathol. Bacteriol. 44:691–697.
Gorer, P. A., 1938, The antigenic basis of tumour transplantation, J. Pathol. Bacteriol. 44:231–252.
Gorer, P. A., 1959, The immunogenetics of cancer, Jaarb. K. Ned. Bot. Ve. 9:90–97.
Gorer, P. A., Lyman, S. and Snell, G. D., 1948, Studies on the genetic and antigenic basis of tumor transplantation: linkage between a histocompatibility gene and “fused” in mice, Proc. Royal Soc. London Ser. B. 135:499–505.
Robinson, J., Waller, M. J., Parham, P., de Groot, N., Bontrop, R., Kennedy, L. J., Stoehr, P. and Marsh, S. G., 2003, IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex, Nucleic Acids Res. 31:311–314.
Gross, L., 1950, Susceptibility of suckling-infant, and resistance of adult, mice of the C3H and of the C57 lines to inoculation with AKR leukemia, Cancer. 3:1073–1087.
Foley, E. J., 1953, Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin, Cancer Res. 13:835–837.
Prehn, R. T. and Main, J. M., 1957, Immunity to methylcholanthrene-induced sarcomas, J. Natl. Cancer Inst. 18:769–778.
Klein, G., 2001, The strange road to the tumor-specific transplantation antigens (TSTAs), Cancer Immunity. 1:6.
Basombrio, M. A., 1970, Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene, Cancer Res. 30:2458–2462.
Burnet, F., 1970, The concept of immunological surveillance, Prog. Exp. Tumor Res. 13:1–27.
Thomas, L., 1982, On immunosurveillance in human cancer, Yale J. Biol. Med. 55:329–333.
Hewitt, H. B., Blake, E. R. and Walder, A. S., 1976, A critique of the evidence for active host defense against cancer, based on personal studies of 27 murine tumours of spontaneous origin, Br. J. Cancer. 33:241–259.
Stutman, O., 1974, Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice, Science. 183:534–536.
Stutman, O., 1975, Immunodepression and malignancy, Adv Cancer Res. 22:261–422.
Pel, A. V., Vessiere, F. and Boon, T., 1983, Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis, J. Exp. Med. 157:1992–2000.
Dye, E. S. and North, R. J., 1981, T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases, J. Exp. Med. 154:1033–1042.
North, R. J., 1982, Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells, J. Exp. Med. 155:1063–1074.
Mills, C. D. and North, R. J., 1983, Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells, J. Exp. Med. 157:1448–1460.
Bursuker, I. and North, R. J., 1984, Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity, J. Exp. Med. 159:1312–1321.
North, R. J. and Bursuker, I., 1984, Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells, J. Exp. Mede. 159:1295–1311.
Bursuker, I. and North, R. J., 1985, Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donors, Cancer Immunology & Immunotherapy. 19:215–218.
Dunn, G. P., Old, L. J. and Schreiber, R. D., 2004, The immunobiology of cancer immunosurveillance and immunoediting, Immunity. 21:137–148.
Pukel, C. S., Lloyd, K. O., Travassos, L. R., Dippold, W. G., Oettgen, H. F. and Old, L. J., 1982, GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody, J. Exp. Med. 155:1133–1147.
De Plaen, E., Lurquin, C., Van Pel, A., Mariame, B., Szikora, J. P., Wolfel, T., Sibille, C., Chomez, P. and Boon, T., 1988, Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation, Proc. Natl. Acad. Sci. U. S. A. 85:2274–2278.
Vijayasaradhi, S., Bouchard, B. and Houghton, A. N., 1990, The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product, J. Exp. Med. 171:1375–1380.
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T., 1991, A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science. 254:1643–1647.
Bowne, W. B., Srinivasan, R., Wolchok, J. D., Hawkins, W. G., Blachere, N. E., Dyall, R., Lewis, J. J. and Houghton, A. N., 1999, Coupling and uncoupling of tumor immunity and autoimmunity, J. Exp. Med. 190:1717–1722.
Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. and Kasper, D. L., 2005, An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system, Cell. 122:107–118.
Houghton, A. N., 1994, Cancer antigens: Immune recognition of self and altered self, J. Exp. Med. 180:1–4.
Matzinger, P., 1994, Tolerance, danger, and the extended family, Ann. Rev. Immunol. 12:991–1045.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Houghton, A.N. (2007). A Perspective on Cancer Immunology and Immunotherapy. In: Kaufman, H.L., Wolchok, J.D. (eds) General Principles of Tumor Immunotherapy. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6087-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6087-8_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6086-1
Online ISBN: 978-1-4020-6087-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)